13
Views
2
CrossRef citations to date
0
Altmetric
Review

Genetic prenatal and preimplantation diagnosis of trinucleotide repeat disorders

&
Pages 561-572 | Published online: 10 Jan 2014

References

  • Weatheral DL. The new genetics and clinical practice. Oxford University Press, Oxford, UK (1991).
  • Cummings CJ, Zoghbi HY. Trinucleotiderepeats: mechanisms and pathophysiology. Ann. Rev Genom. Human. Genet.1, 281–328 (2000).
  • ••Excellent summary of the currentunderstanding of trinucleotide repeat orders.
  • Holmes SE, O'Hearn E, Rosenblatt A et alA repeat expansion in the gene encoding junctophilin-3 is associated with Huntington's disease-like 2. Nat. Genet. 29(4),377-378 (2001).
  • Nakamura K, Jeong SY, Uchihara T et a/.SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mal Genet 10(14),1441–1448 (2001).
  • Massari A, Novelli G, Colosimo A etal. Non-invasive early prenatal molecular diagnosis using retrieved transcervical trophoblast cells. Hum Genet. 97(2), 150–155 (1996).
  • Amicucci P, Gennarelli M, Novelli G,Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin. Chem. 46(2), 301–302 (2000).
  • Edwards RG. Maturation in vitro of human ovarian oocytes. Lancet ii, 926–929 (1965).
  • Handyside AH, Kontogianni IEH, HardyK, Winston RM, Hughes MR. Birth of a normal girl after in vitro fertilisation and preimplantation diagnostic testing for cystic fibrosis. NEngif Med. 372 (13), 905–909 (1992).
  • McKusick VA. Mendelian Inheritance in Mm. Catalogs of Human Genes and Genetic Disorders. (12th edition). Johns Hopkins University Press, Baltimore, USA (1998).
  • Dean NL, Phillips SJ, Buckett WM, Biljan MM, Tan SL. Impact of reducing the number of embryos transferred from three to two in women under the age of 35 who produced three or more high quality embryos. Fetid. Stern. 74(4), 820–823 (2000).
  • Dean NL, Tan SL, Ao A. The development of preimplantation genetic diagnosis for myotonic dystrophy using multiplex fluorescent polymerase chain reaction and its clinical application. Mal Hum. Reprod. 7(9), 895–901 (2001).
  • Sermon K, Seneca S, De Rycke M et alPGD in the lab for triplet repeat diseases - myotonic dystrophy, Huntington's disease and Fragile-X syndrome. Mal Cell Endocrinol 183\(Suppl. 1), S77-85 (2001).
  • ••5-year experience of PGD for FRAXA,HD and DM1.
  • Nance MA, Myers RII. Juvenile onset Huntington's disease - clinical and research perspectives. Ment. Retard. Dev. Disabil Res. Rev 7(3), 153–157 (2001).
  • Hayden MR, Hewitt J, Kastelein JJ etal First-trimester prenatal diagnosis for Huntington's disease with DNA probes. Lancet1(8545), 1284–1285(1987).
  • Quarrell OW Meredith AL, Tyler A,Youngman S, Upadhyaya M, Harper PS. Exclusion testing for Huntington's disease in pregnancy with a closely linked DNA marker. Lancet1(8545), 1281–1283 (1987).
  • Rosser E, Huson SM, Norbury G. Prenatal, presymptomatic and diagnostic testing with direct mutation analysis in Huntington's disease. Lancet343(8895), 487–488 (1994).
  • Fahy M, Robbins C, Bloch M, Turnell RW,Hayden MR. Different options for prenatal testing for Huntingtonis disease using DNA probes. Med. Genet. 26(6), 353-357(1989).
  • Sermon K, Goossens V, Seneca S eta].Preimplantation diagnosis for Huntington's disease (HD): clinical application and analysis of the HD expansion in affected embryos. Prenat. Diagn. 18 (13), 1427–1436 (1998).
  • Schulman JD, Black SH, Handyside AH,Nance WE. Preimplantation genetic testing for Huntington's disease and certain other dominantly inherited diseases. Clin. Genet. 49(2), 57–58 (1996).
  • Yapijakis C, Kapaki E, Boussiou M, Vassilopoulos D, Papageorgiou C. Prenatal diagnosis of X-linked spinal and bulbar muscular atrophy in a Greek family. Prenat. Diagn. 16(3), 262–265 (1996).
  • Georgiou I, Sermon K, Lissens W et alPreimplantation genetic diagnosis for spinal and bulbar muscular atrophy (SBMA). Hum. Genet. 108(6), 494–498 (2001).
  • Sequeiros J, Maciel P, Taborda F et alPrenatal diagnosis of Machado-Joseph disease by direct mutation analysis. Prenat. Diagn. 18(6), 611–617(1998).
  • •Good discussion of the controversial issues in prenatal diagnosis for late onset genetic disorders.
  • Grattan-Smith PJ, Healey S, Grigg JR,Christodoulou J. Spinocerebellar ataxia Type 7: a distinctive form of autosomal dominant cerebellar ataxia with retinopathy and marked genetic anticipation. j Pediatr. Child Health 37(1), 81–84 (2001).
  • Magee AC, Hughes AE, Kidd A etalReproductive counselling for women with myotonic dystrophy. j Med. Genet. 39(3), e15 (2002).
  • Brook J, McCurrach M, Harley H etal.Molecular basis of myotonic dystrophy: expansion of trinucleotide (CTG) repeat at 3' end of a transcript encoding a protein kinase family member. Ce//68(4), 799–808 (1992).
  • Mahadevan M, Tsilfidis C, Sabourin L etalMyotonic dystrophy: an unstable CTG repeat in the 3- untranslated region of the gene. Science255(5049), 1253–1255 (1992).
  • Insley J, Bird GW, Harper PS, Pearce GW.Letter: Prenatal prediction of myotonicdystrophy. Lancet1(7963), 806 (1976).
  • Greiner J, Spengler DH, Kruger J,Tariverdian G. The secretor locus as a marker for prenatal prediction of myotonic dystrophy (DM). Hum. Genet. 78(4), 330–332 (1988).
  • Lunt PW, Meredith AL, Harper PS. First-trimester prediction in fetus at risk for myotonic dystrophy. Lancet 2 (8502), 350–351 (1986).
  • Lavedan C, Hofmann H, Shelbourne Petal Prenatal diagnosis of myotonic dystrophy using closely linked flanking markers.j Med Genet. 28(2), 89–91 (1991).
  • Mulley JC, Gedeon AK, White SJ, Haan EA, Richards RI. Predictive diagnosis of myotonic dystrophy with flanking microsatellite markers. j Med. Genet 28(7), 448–452 (1991).
  • Smeets HJ, Nillesen WM, Los F etalPrenatal diagnosis of myotonic dystrophy by direct mutation analysis. Lancet 340(8813), 237–238 (1992).33Petronis A, Heng IIf I, Tatuch Y etal Direct detection of expanded trinucleotide repeats using PCR and DNA hybridization techniques. Am.j Hum Genet. 67(1), 85-91(1996).
  • Cheng S, Barcelo JM, Korneluk RG.Characterization of large CTG repeat expansions in myotonic dystrophy alleles using PCR. Hum. .11/lutat. 7(4), 304–310 (1996).
  • Sermon K, Lissens W, Joris H etal Clinicalapplication of preimplantation diagnosisfor myotonic dystrophy. Prenat. Diagn.17(10), 925–932 (1997).
  • Sermon K, De Vos A, Van de Velde H etalFluorescent PCR and automated fragment analysis for the clinical application of preimplantation genetic diagnosis of myotonic dystrophy (Steinerts disease) Mal Hum. Reprod 4(8), 791–796 (1998).
  • Prouty LA, Rogers RC, Stevenson RE et al.Fragile X syndrome: growth, development and intellectual function. Am. j Hum. Genet. 30(1-2), 123–142 (1988).
  • Verkerk AJMH, Pieretti M, Sutcliffe JS etal Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Ce1165(5), 905–914 (1991).
  • Oberle I, Rousseau F, Heitz D. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252 (5010), 1097–1102 (1991).
  • Sutcliffe JS, Nelson DL, Zhang F etal DNA methylation represses FMR-1 transcription in fragile X syndrome Hum. Mol. Genet. 1(6), 397–400 (1992).
  • Jenkins EC, Brown WT, Brooks J, DuncanCJ, Rudelli RD, Wisniewski HM. Experience with prenatal fragile X detection. Am. Med Genet 17(1), 215–239 (1984).
  • Forster-Gibson CJ, Mulligan LM, Simpson NE, White BN, Holden JJ. An assessment of the use of flanking DNA markers for fra(X) syndrome carrier detection and prenatal diagnosis Am. j Med. Genet. 23 (1–2), 665–683 (1986).
  • Tarleton J, Wong S, Heitz D, Schwartz C.Difficult diagnosis of the fragile X syndrome made possible by direct detection of DNA mutations. .1. Med. Genet. 29(10), 726–729 (1992).
  • Rousseau F, Heitz D, Biancalana V etal Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N. Engl. Med 325(24), 1673–1681 (1991).
  • Sutherland GR, Gedeon A, Kornman Letal Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. N Engl. I Med. 325(24), 1720–1722 (1991).
  • Brown WT, Houck GE Jr, Jeziorowska Aetal Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JA/V/A 270(13), 1569–1575 (1993).
  • Dobkin C, Ding X, Li Y etal Accelerated prenatal diagnosis of Fragile X syndrome by polymerase chain reaction restriction fragment detection. Am. j Med. Genet 83(40), 338–342 (1999).
  • Dreesen JCFM, Geraedts JPM, DumoulinJCM, Evers JLH, Pieters MHEC. R546 (DX5548) genotyping of reproductive cells: approaching preimplantation testing of the fragile-X syndrome. Hum. Genet 96(3), 323–329 (1995).
  • Reyniers E, Vits L, De Boulle L etal The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat. Genet. 4(2), 143–146 (1993).
  • Apessos A, Abou-Sleiman PM, Harper JC, Delhanty JD. Preimplantation genetic diagnosis of the fragile X syndrome by use of linked polymorphic markers. Prenat. Diagn. 21(6), 504–511(2001).
  • Sermon K, Seneca S, Vanderfaeillie A etal Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG. Prenat. Diagn. 19(13), 1223–1230 (1999).
  • Maher H, Iber J, Willemsem R etalCharacterization of the full fragile X syndrome mutation in fetal gametes. Nat. Genet. 15(2), 165–169 (1997).
  • Campuzano V, Montermini L, Moho MDetal Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271(5254), 1423–1427(1996).
  • Wallis J, Shaw J, Wilkes D etal Prenataldiagnosis of Friedreich ataxia. Am. j Med. Genet. 34(3), 458–461 (1989).
  • Pandolfo M, Montermini M. Prenatal diagnosis of Friedreichs ataxia. Prenat. Diagn. 18(8), 831–833 (1998).
  • Knight SJ, Flannery AV, Hirst MC etalTrinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74(1), 127–134 (1993).
  • Biancalana V, Tame L, Bouix J-C etalExpansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males. Am j Hum. Genet. 59(4), 847–854 (1996).
  • Carbonell P, Lopez I, Gabarron J eta]. FRAXE mutation analysis in three Spanish families. Arnj Med. Genet. 64(2), 434–440 (1996).
  • Hagerman RJ, Hull CE, Safanda JF et alHighfunctioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am jMJ Genet. 51(4), 298–308 (1994).
  • Hecimovic S, Barasic I, Muller A, PetkovicI, Ligutic I, Pavelic K. Expand long PCR for fragile X mutation detection. Clin. Genet. 52(3), 147–154 (1997).
  • Allingham-Hawkins DJ, Babul-Hirji R,Chitayat D etal Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. J. Med. Genet. 83(4), 322–325 (1999).
  • Lewis CM, Pinel T, Whittaker JC et al Controlling misdiagnosis errors in preimplantation genetic diagnosis: a comprehensive model encompassing extrinsic and intrinsic sources of error. Hum. Repmd. 16(1), 43–50 (2001).
  • Pergament E. Preimplantation diagnosis: a patient perspective. Prenat. Diagn. 11(8), 493–500 (1991).
  • Willemsen R, Oosterwijk JC, Los FJ,Galjaard H, Oostra BA. Prenatal diagnosis of fragile X syndrome. Lancet 348(9032), 967–968 (1996).
  • Jenkins EC, Wen GY, Kim KS, Zhong Netal Prenatal fragile X detection using cytoplasmic and nuclear-specific monoclonal antibodies. Am. J. Med. Genet. 83(4), 342–346 (1999).
  • Gardner DK, Vella P, Lane M, Wagley L, Schlenker T, Schoolcraft WB. Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil 69 (1), 84–88 (1998).
  • Andrew SE, Goldberg YP, Kremer B etalThe relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat. Genet. 4(4), 398–403 (1993).
  • The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's Disease chromosomes. Cell 72(6), 971–983 (1993).
  • Duyao M, Ambrose C, Myers R etal Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat. Genet. 4(4), 387–392 (1993).
  • Chung M-Y, Ranum LPW, Duvick L, Sevadio A, Zoghbi HY, Orr HR. Analysis of the CAG repeat expansion in spinocerebellar ataxia Type 1: evidence for a possible mechanism predisposing to instability. Nat. Genet. 5(3), 254–258 (1993).
  • Orr HT, Chung M-Y, Banfi S etalExpansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia Type 1. Nat. Genet. 4(3), 221–226 (1993).
  • Imbert G, Sandou F, Yvert G etal Cloning ofthe gene for spinocerebellar ataxia Type 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats and high instability. Nat. Genet. 14(3), 285–291 (1996).
  • NIA S-M, Nechiporuk A, Nechiporuk Tetal Identification of the SCA2 gene: moderate expansion of a normally biallelic trinucleotide repeat. Nat. Genet. 14(3), 269–276 (1996).
  • Kawaguchi Y, Okamoto T, Taniwaki M etalCAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 8(3), 221–228 (1994).
  • Maciel P, Gaspar C, DeStefano AL etalCorrelation between CAG repeat length and clinical features in Machado-Joseph disease.Am jHurn Genet. 57(1), 54–61(1995).
  • Jodice C, Mantuano E, Veneziano L etal Episodic ataxia Type 2 (EA2) and spinocerebellar ataxia 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum. Mal. Genet. 6(11), 1973–1978 (1997).
  • Zhuchenko 0, Bailey J, Bonnen P etalAutosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the oclA-voltage-dependent calcium channel. Nat. Genet. 15(1), 62–69 (1997).
  • David G, Abbas N, Stevanin G etalCloning of the SCA7 gene reveals a highly stable CAG unstable expansion. Nat. Genet. 17(1), 65–70 (1997).
  • Benton CS, de Silva R, Rutledge SL etalMolecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurology51 (4), 1081–1086 (1998).
  • Koide R, Ikeuchi T, Onodera 0 etalUnstable expansion of CAG repeat in dentatorubral-pallidoluysian atrophy (DRPLA). Nat. Genet. 6(1), 9–13 (1994).
  • La Spada AR, Wilson EM, Lubahn DB,Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352(6330), 77–79 (1991).
  • La Spada AR, Roling DB, Harding AEetal Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbarmuscular atrophy. Nat. Genet. 2(4), 301–304 (1992).
  • Fu YH, Pizzuti A, Fenwick RG Jr etal An unstable triplet repeat in a gene related tomyotonic muscular dystrophy. Science255(5049), 1256–1258(1992).
  • Koob MD, Moseley ML, Schut LJ etal An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat. Genet. 21(4), 379–384 (1999).
  • Ranum LPW, Moseley ML, Leppert MFetal Massive CTG expansions and deletions may reduce penetrance of spinocerebellar ataxia Type 8. Am. J. Hum. Genet. 65 (Suppl.), A466 (1999).
  • Holmes SE, O'Hearn EE, McInnes MG etal Expansion of a novel CAG trinucleotide repeat in the 5' region of PP2R2B is associated with SCA12. Nat. Genet. 23(4), 391–392 (1999).
  • Fujigasaki H, Verma IC, Camuzat A etal SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann. Neural. 49(1), 117–121 (2001).
  • Fu YH, Kuhl DP, Pizzuti A etal Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67(6), 1047–1058 (1991).
  • Yu S, Mulley J, Loesch D etal Fragile Xsyndrome: unique genetics of the heritable unstable element. Amj Hum Genet. 50(5), 968–980 (1992).
  • Sutherland GR, Baker E. Characterisation of a new rare fragile site easily confused with the fragile X. Hum. Mal Genet. 1(2), 111–113 (1992).
  • Montermini L, Andermann E, Richter Aetal The Friedreich ataxia FAA triplet repeat: premutation and normal alleles. Hum. Mal. Genet. 6(8), 1261–1266 (1997).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.